Table 2.
Dose 1 | Dose 2 | ||||
---|---|---|---|---|---|
COVID19 Vaccine | anti-SPIKE IgGa | IgGb (UI ml−1) | anti-SPIKE IgGa | IgGb (UI ml−1) | n |
Sputnik | 75% | 164 ± 39 | 100% | 414 ± 49 | 16 |
AstraZeneca | 80 | 250 ± 56 | 100% | 416 ± 44 | 15 |
Sinopharm | 25% | 70 ± 45 | 88% | 213 ± 36 | 16 |
n Individuals tested.
Percentages of seroconversion post-COVID 19 vaccination.
Anti-SPIKE IgG titer in blood serum.